Titration	O
of	O
Ab	O
-	O
01	O
inhibition	O
of	O
ex	O
vivo	O
response	O
to	O
rhIL21	O

Samples	B-Organism_substance
from	O
4	O
individual	O
healthy	O
human	O
donors	O
were	O
pre	O
-	O
incubated	O
for	O
2	O
hours	O
at	O
the	O
indicated	O
concentration	O
of	O
Ab	O
-	O
01	O
or	O
the	O
control	O
IgG1TM	O
prior	O
to	O
addition	O
of	O
10	O
ng	O
/	O
mL	O
rhIL21	O
and	O
2	O
hr	O
incubation	O
,	O
and	O
the	O
effect	O
on	O
the	O
6	O
biomarkers	O
was	O
then	O
assessed	O
(	O
Figures	O
4	O
and	O
5	O
)	O
.	O

For	O
the	O
first	O
2	O
donors	O
tested	O
,	O
even	O
the	O
lowest	O
concentration	O
of	O
Ab	O
-	O
01	O
(	O
0	O
.	O
1	O
mug	O
/	O
mL	O
,	O
0	O
.	O
66	O
nM	O
)	O
resulted	O
in	O
complete	O
inhibition	O
of	O
the	O
rhIL21	O
response	O
,	O
therefore	O
the	O
two	O
subsequent	O
donors	O
were	O
tested	O
at	O
increasing	O
concentrations	O
of	O
Ab	O
-	O
01	O
starting	O
at	O
0	O
.	O
003	O
mug	O
/	O
mL	O
.	O

Ab	O
-	O
01	O
inhibited	O
the	O
response	O
of	O
all	O
6	O
genes	O
in	O
all	O
4	O
donors	O
.	O

IC50	O
values	O
ranged	O
between	O
0	O
.	O
003	O
and	O
0	O
.	O
015	O
mug	O
/	O
mL	O
Ab	O
-	O
01	O
(	O
Figure	O
5	O
)	O
.	O

Control	O
IgG1TM	O
had	O
no	O
significant	O
effect	O
on	O
rhIL21	O
response	O
(	O
Figure4B	O
)	O
.	O

Figure	O
4	O

Average	O
percent	O
inhibition	O
of	O
the	O
expression	O
level	O
of	O
6	O
IL21	O
-	O
responsive	O
genes	O
.	O

Percent	O
inhibition	O
values	O
were	O
calculated	O
based	O
on	O
RQ	O
(	O
relative	O
quantification	O
)	O
values	O
of	O
untreated	O
control	O
and	O
rhIL21	O
-	O
treated	O
samples	B-Organism_substance
for	O
each	O
of	O
the	O
4	O
donors	O
,	O
and	O
subsequently	O
the	O
mean	O
and	O
standard	O
deviation	O
were	O
determined	O
for	O
each	O
gene	O
shown	O
.	O

A	O
:	O
Percent	O
inhibition	O
in	O
presence	O
of	O
Ab	O
-	O
01	O
.	O

B	O
:	O
Percent	O
inhibition	O
in	O
presence	O
of	O
control	O
IgG1TM	O
.	O

Data	O
for	O
the	O
0	O
.	O
1	O
mug	O
/	O
mL	O
,	O
0	O
.	O
3	O
mug	O
/	O
mL	O
and	O
1	O
mug	O
/	O
mL	O
concentrations	O
were	O
generated	O
using	O
4	O
donors	O
.	O

Data	O
for	O
the	O
higher	O
and	O
the	O
lower	O
concentrations	O
were	O
generated	O
using	O
2	O
donors	O
.	O

Figure	O
5	O

Inhibition	O
by	O
Ab	O
-	O
01	O
at	O
the	O
indicated	O
concentration	O
is	O
shown	O
for	O
6	O
IL21	O
-	O
responsive	O
genes	O
.	O

IC50	O
values	O
of	O
inhibition	O
curves	O
shown	O
in	O
Figure	O
4A	O
were	O
calculated	O
using	O
curve	O
fit	O
(	O
XLfit	O
)	O
program	O
for	O
each	O
of	O
the	O
referred	O
biomarker	O
genes	O
.	O

Values	O
for	O
the	O
0	O
.	O
1	O
mug	O
/	O
mL	O
,	O
0	O
.	O
3	O
mug	O
/	O
mL	O
and	O
1	O
mug	O
/	O
mL	O
concentrations	O
were	O
generated	O
using	O
4	O
donors	O
.	O

Data	O
for	O
the	O
higher	O
and	O
the	O
lower	O
concentrations	O
were	O
generated	O
using	O
2	O
donors	O
each	O
.	O

